Treatments for behavioural disorders in neurodegenerative diseases: drug development strategies
Identifieur interne : 001172 ( Main/Exploration ); précédent : 001171; suivant : 001173Treatments for behavioural disorders in neurodegenerative diseases: drug development strategies
Auteurs : Jeffrey L. Cummings [États-Unis] ; Kate Zhong [États-Unis]Source :
- Nature Reviews Drug Discovery [ 1474-1776 ] ; 2006-01.
Abstract
Neuropsychiatric symptoms and behavioural alterations are common in neurodegenerative diseases, and effective treatment of these changes represents an important unmet public health need. Imaging, neuropathological, neurotransmitter and molecular genetic studies increasingly identify specific mechanisms that mediate behavioural changes in neurodegenerative disorders and provide a platform for seeking effective therapeutic interventions. Measuring behavioural outcomes in clinical trials of antidementia agents represents an important means of evaluating treatment effectiveness, and clinical trial methodologies and behavioural instrumentation are evolving to facilitate drug development in this important therapeutic target area.
Url:
DOI: 10.1038/nrd1928
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatments for behavioural disorders in neurodegenerative diseases: drug development strategies</title>
<author><name sortKey="Cummings, Jeffrey L" sort="Cummings, Jeffrey L" uniqKey="Cummings J" first="Jeffrey L." last="Cummings">Jeffrey L. Cummings</name>
</author>
<author><name sortKey="Zhong, Kate" sort="Zhong, Kate" uniqKey="Zhong K" first="Kate" last="Zhong">Kate Zhong</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:89FEFB9AB8AA61253632E533E4D6BA817582DD07</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1038/nrd1928</idno>
<idno type="url">https://api.istex.fr/document/89FEFB9AB8AA61253632E533E4D6BA817582DD07/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">001780</idno>
<idno type="wicri:Area/Main/Curation">001537</idno>
<idno type="wicri:Area/Main/Exploration">001172</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Treatments for behavioural disorders in neurodegenerative diseases: drug development strategies</title>
<author><name sortKey="Cummings, Jeffrey L" sort="Cummings, Jeffrey L" uniqKey="Cummings J" first="Jeffrey L." last="Cummings">Jeffrey L. Cummings</name>
<affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Department of Neurology, 710 Westwood Plaza, David Geffen School of Medicine, UCLA, Los Angeles, California 90095</wicri:regionArea>
<wicri:noRegion>California 90095</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Zhong, Kate" sort="Zhong, Kate" uniqKey="Zhong K" first="Kate" last="Zhong">Kate Zhong</name>
<affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>MediChamp, 37 Grayson Lane, Newton, Massachusetts 02462</wicri:regionArea>
<wicri:noRegion>Massachusetts 02462</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Nature Reviews Drug Discovery</title>
<idno type="ISSN">1474-1776</idno>
<idno type="eISSN">1474-1784</idno>
<imprint><publisher>Nature Publishing Group</publisher>
<date type="published" when="2006-01">2006-01</date>
<biblScope unit="volume">5</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="64">64</biblScope>
<biblScope unit="page" to="74">74</biblScope>
</imprint>
<idno type="ISSN">1474-1776</idno>
</series>
<idno type="istex">89FEFB9AB8AA61253632E533E4D6BA817582DD07</idno>
<idno type="DOI">10.1038/nrd1928</idno>
<idno type="ArticleID">nrd1928</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1474-1776</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="eng">Neuropsychiatric symptoms and behavioural alterations are common in neurodegenerative diseases, and effective treatment of these changes represents an important unmet public health need. Imaging, neuropathological, neurotransmitter and molecular genetic studies increasingly identify specific mechanisms that mediate behavioural changes in neurodegenerative disorders and provide a platform for seeking effective therapeutic interventions. Measuring behavioural outcomes in clinical trials of antidementia agents represents an important means of evaluating treatment effectiveness, and clinical trial methodologies and behavioural instrumentation are evolving to facilitate drug development in this important therapeutic target area.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
</list>
<tree><country name="États-Unis"><noRegion><name sortKey="Cummings, Jeffrey L" sort="Cummings, Jeffrey L" uniqKey="Cummings J" first="Jeffrey L." last="Cummings">Jeffrey L. Cummings</name>
</noRegion>
<name sortKey="Cummings, Jeffrey L" sort="Cummings, Jeffrey L" uniqKey="Cummings J" first="Jeffrey L." last="Cummings">Jeffrey L. Cummings</name>
<name sortKey="Zhong, Kate" sort="Zhong, Kate" uniqKey="Zhong K" first="Kate" last="Zhong">Kate Zhong</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001172 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001172 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:89FEFB9AB8AA61253632E533E4D6BA817582DD07 |texte= Treatments for behavioural disorders in neurodegenerative diseases: drug development strategies }}
This area was generated with Dilib version V0.6.23. |